title: A family of serine proteases expressed exclusively in myelo-monocytic cells specifically processes the nuclear factor-kappa B subunit p65 in vitro and may impair human immunodeficiency virus replication in these cells.
abstract: Two groups of U937 promonocytic cells were obtained by limiting dilution cloning which differed strikingly in their ability to support human immunodeficiency virus 1 (HIV-1) replication. "Plus" clones replicated the virus efficiently, whereas "minus" clones did not. We examined these clones for differences in nuclear factor (NF)-kappa B activity which might account for the observed phenomenon. Stimulation of plus clones liberated the classical p50-p65 complex from cytoplasmic pools, whereas minus clones produced an apparently novel, faster-migrating complex, as judged by electrophoretic mobility shift assays. It is surprising that the faster-migrating complex was composed also of p50 and p65. However, the p65 subunit was COOH-terminally truncated, as shown by immunoprecipitation. The truncation resulted from limited proteolysis of p65 during cellular extraction which released particular lysosomal serine proteases, such as elastase, cathepsin G, and proteinase 3. These specific proteases are coordinately expressed and were present exclusively in the minus U937 clones, but not in the plus clones, as demonstrated in the case of cathepsin G. In addition, these proteases were detected in certain subclones of THP-1 and HL-60 cells and in primary monocytes, in each case correlating with the truncated from of p65. We demonstrate in vitro cleavage of p65 by purified elastase and cathepsin G. It is possible that particular serine proteases may have inhibiting effects on the replication of HIV-1 in myelo-monocytic cells. The data also demonstrate that special precautions must be taken when making extracts from myelo-monocytic cells.
authors.affiliation: Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892.
authors.forename: G
authors.initials: G
authors.lastname: Franzoso
authors.forename: P
authors.initials: P
authors.lastname: Biswas
authors.forename: G
authors.initials: G
authors.lastname: Poli
authors.forename: L M
authors.initials: LM
authors.lastname: Carlson
authors.forename: K D
authors.initials: KD
authors.lastname: Brown
authors.forename: M
authors.initials: M
authors.lastname: Tomita-Yamaguchi
authors.forename: A S
authors.initials: AS
authors.lastname: Fauci
authors.forename: U K
authors.initials: UK
authors.lastname: Siebenlist
mesh_terms: D000818:Animals; D015497:HIV-1 / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D009000:Monocytes / Q000201:enzymology*; D016328:NF-kappa B / Q000378:metabolism*; D011817:Rabbits; D012697:Serine Endopeptidases / Q000494:pharmacology*; D051996:Transcription Factor RelA; D014407:Tumor Cells, Cultured; D014779:Virus Replication / Q000187:drug effects*
chemical_list: D016328:NF-kappa B; D051996:Transcription Factor RelA; D012697:Serine Endopeptidases